Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis-Reference-Cited by-同舟云学术

Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis

Published:2020-02 Issue: Volume:152 Page:104594
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Hamzic Seid,Kummer Dominic,Froehlich Tanja K.,Joerger Markus,Aebi Stefan,Palles Claire,Thomlinson Ian,Meulendijks Didier,Schellens Jan H.M.,García-González Xandra,López-Fernández Luis A.,Amstutz Ursula,Largiadèr Carlo R.

Funder

Swiss National Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology

Reference37 articles.

1. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue;Miwa;Eur. J. Cancer,1998

2. Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer;Wagstaff;Drugs,2003

3. 5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials;Petrelli;Med. Oncol.,2012

4. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study;Primrose;Lancet Oncol.,2019

5. Clinical relevance of DPYD variants c.1679T&G, c.1236G&A/HapB3, and c.1601G&A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data;Meulendijks;Lancet Oncol.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis;British Journal of Cancer;2024-01-15

2. Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer;International Journal of Molecular Sciences;2023-12-20

3. Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia;Frontiers in Pharmacology;2023-09-08

4. Clinical importance of TYMS and ENOSF1 genetic variants and mRNA expression levels in response to chemotherapy in Iranian gastric cancer patients;2023-05-23

5. Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?;Frontiers in Pharmacology;2023-05-15